Cargando…

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma

Osteolytic destruction is a hallmark of multiple myeloma, resulting from activation of osteoclast-mediated bone resorption and reduction of osteoblast-mediated bone formation. However, the molecular mechanisms underlying the differentiation and activity of osteoclasts and osteoblasts within a myelom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huan, He, Jin, Bagheri-Yarmand, Rozita, Li, Zongwei, Liu, Rui, Wang, Zhiming, Bach, Duc-hiep, Huang, Yung-hsing, Lin, Pei, Guise, Theresa A., Gagel, Robert F., Yang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237076/ https://www.ncbi.nlm.nih.gov/pubmed/35760800 http://dx.doi.org/10.1038/s41467-022-31356-7

Ejemplares similares

Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance
por: Wang, Zhiming, et al.
Publicado: (2022)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

Overexpression of CIITA in T Cells Aggravates Th2-Mediated Colitis in Mice
por: Kim, Tae Woon, et al.
Publicado: (2006)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023)

Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

m(6)A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease
por: Liu, Rui, et al.
Publicado: (2022)

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
por: Rossi, J. F., et al.
Publicado: (1984)

CIITA and Its Dual Roles in MHC Gene Transcription
por: Devaiah, Ballachanda N., et al.
Publicado: (2013)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma
por: Idowu, Bukunmi Michael
Publicado: (2017)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

Identification of CIITA Regulated Genetic Module Dedicated for Antigen Presentation
por: Krawczyk, Michal, et al.
Publicado: (2008)

CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Iizuka, N, et al.
Publicado: (2004)

A dual defensive role of CIITA against retroviral infections
por: Tosi, Giovanna, et al.
Publicado: (2006)

SIRT1 links CIITA deacetylation to MHC II activation
por: Wu, Xiaoyan, et al.
Publicado: (2011)

Mechanical Loading Differentially Affects Osteocytes in Fibulae from Lactating Mice Compared to Osteocytes in Virgin Mice: Possible Role for Lacuna Size
por: Hemmatian, Haniyeh, et al.
Publicado: (2018)

Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands
por: Wang, Rui-An, et al.
Publicado: (2003)

Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Osteolytic lesions in myelofibrosis
por: Johnson, Isla, et al.
Publicado: (2021)

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
por: Tavel, Laurette, et al.
Publicado: (2016)

Identification of candidate genes for myeloma-induced osteocyte death based on microarray data
por: Tian, Honglai
Publicado: (2016)

Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23
por: Mulcrone, Patrick L., et al.
Publicado: (2020)

Molecular mechanosensors in osteocytes
por: Qin, Lei, et al.
Publicado: (2020)

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

IFN-γ and CIITA modulate IL-6 expression in skeletal muscle
por: Adhikari, Abhinav, et al.
Publicado: (2020)

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma
por: Yang, Jing, et al.
Publicado: (2012)

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo
por: Lwin, S. T., et al.
Publicado: (2017)

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Osteolytic Lesion of the Maxilla in an Undiagnosed Multiple Myeloma Patient Identified Incidentally by Cone Beam Computed Tomography
por: Ali, Sarah AlFarabi, et al.
Publicado: (2022)

Tuberculosis of the foot: An osteolytic variety
por: Dhillon, Mandeep S, et al.
Publicado: (2012)

Solitary Tibial Osteolytic Lesion
por: Pakos, Emilios E., et al.
Publicado: (2009)

Pathological fracture on osteolytic lesion
por: Traore, Ousmane, et al.
Publicado: (2021)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

The Amazing Osteocyte
por: Bonewald, Lynda F
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m4pgf1kt945q007qf4r1sdke4q